Ralph Wendt
Klinikum St. Georg(DE)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Cardiovascular Conditions and Treatments, Animal Virus Infections Studies, COVID-19 Clinical Research Studies, Complement system in diseases
Most-Cited Works
- → Development and validation of a renal risk score in ANCA-associated glomerulonephritis(2018)280 cited
- → Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura(2020)114 cited
- → Urine proteomics for prediction of disease progression in patients with IgA nephropathy(2020)77 cited
- → ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP(2020)73 cited
- → A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients(2021)47 cited
- → Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura(2023)43 cited
- → Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial(2020)35 cited
- → Mechanical aortic valve prostheses offer a survival benefit in 50–65 year olds: AUTHEARTVISIT study(2021)32 cited
- → Urinary Peptides Significantly Associate with COVID‐19 Severity: Pilot Proof‐of‐Principle Data and Design of a Multicentric Diagnostic Study(2020)31 cited
- → Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study(2022)29 cited